Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001558370-19-003404
Filing Date
2019-04-26
Accepted
2019-04-26 16:03:37
Documents
4
Period of Report
2019-06-07
Effectiveness Date
2019-04-26

Document Format Files

Seq Description Document Type Size
1 DEF 14A axsm-20190607xdef14a.htm DEF 14A 685402
2 GRAPHIC axsm20190607xdef14a001.jpg GRAPHIC 17967
3 GRAPHIC axsm20190607xdef14a002.jpg GRAPHIC 310909
4 GRAPHIC axsm20190607xdef14a003.jpg GRAPHIC 276799
  Complete submission text file 0001558370-19-003404.txt   1520600
Mailing Address 200 BROADWAY, 3RD FLOOR NEW YORK NY 10038
Business Address 200 BROADWAY, 3RD FLOOR NEW YORK NY 10038 (212) 332-3241
Axsome Therapeutics, Inc. (Filer) CIK: 0001579428 (see all company filings)

EIN.: 454241907 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37635 | Film No.: 19771723
SIC: 2834 Pharmaceutical Preparations